
David Zheng (郑夏喆), MD
@davidxzheng
Followers
1K
Following
5K
Media
133
Statuses
1K
PGY-3 @MGHMedicine @HarvardMed 🩺 // @Princeton 🐯 @CWRUSOM 👨🏻⚕️ // Editorial Trainee @BrJDermatol 📚 // Melanoma & Tumor Immunology 🦠
Boston, MA
Joined August 2018
RT @BrJDermatol: We are seeking a new BJD Associate Editor for the Outcomes and Qualitative Research section!. If you feel you would be a g….
academic.oup.com
Role Title: Associate Editor Reports to: Editor-in-Chief Direct Reports: Section
0
3
0
RT @BrJDermatol: We are delighted to announce the relaunch of the BJD Talks podcast!. The new episodes are AI-generated and designed to pro….
0
2
0
RT @TyHaliburton22: Man. Don’t know how to explain it other than shock. Words cannot express the pain of this letdown. The frustration is u….
0
67K
0
Check out our review on the role of patient-derived 3D tumor model systems in precision medicine for cancer immunotherapy!. @MGHCancerCenter
0
0
3
RT @Schmeelk: Knicks-Pacers history 🧵 for the younger fans that did not experience the 90's rivalry. 1. These teams met 6 times from 1993….
0
335
0
RT @BrJDermatol: Happy Sun Awareness Week! ☀️. #SunAwarenessWeek is the BAD’s annual campaign to encourage everyone to protect their skin f….
blog.oup.com
Kicking off today, Sun Awareness Week (12-18 May) is the start of the British Association of Dermatologists’ (BAD) summer-long campaign to encourage everyone to protect their skin from sun damage and...
0
3
0
RT @EricTopol: Of >105,000 participants with 30-year follow-up, only 9.3% achieved healthy aging (age 70, w/o any chronic diseases). Their….
0
1K
0
RT @mghmedres: Congratulations to our incredible incoming interns on their Match today!! We are so excited to have you join the family this….
0
10
0
RT @BrJDermatol: New research published in the BJD has found that applying a common food additive to hair follicles can activate taste rece….
0
4
0
RT @BrianHie: We trained a genomic language model on all observed evolution, which we are calling Evo 2. The model achieves an unprecedent….
0
326
0
RT @BrianHie: Grateful to @QuantaMagazine for covering the research done by the incredible Evo team! We are hard at work on the next genera….
0
3
0
Excited to share our invited editorial in @BrJDermatol on McGillivray et al.'s analysis of real-world outcomes for combined PD-1 and CTLA-4 immune checkpoint blockade in acral lentiginous melanoma. Link below!.
1
4
20
Using the Veterans Health Administration (VHA) Corporate Data Warehouse, we found that, since 2014, derm appointment wait times increased overall and in the community, but decreased at VHA facilities. Thanks to @MelissaLevoska, @ThomasCwalina, and team!.
0
0
6
RT @tess_omeara: Excited to share my recently published perspective in @NEJM on the clinical implications of DESTINY-Breast06. Which patien….
0
10
0
RT @BrianHie: In new work led by @aditimerch with @samuelhking, we prompt engineer Evo to perform function-guided protein design with high….
0
126
0
RT @AmJClinDerma: This review by Russell W. Jenkins and colleagues summarizes recent advancements in melanoma immunotherapy with an emphasi….
link.springer.com
American Journal of Clinical Dermatology - The advent of immune checkpoint inhibition has revolutionized treatment of advanced melanoma. While most patients derive survival benefit from established...
0
2
0
RT @villanilab: ⭐️NEW PAPER OUT in @Nature⭐️. 🫀What is the relationship between the immune responses in the heart, blood, and tumor in pati….
nature.com
Nature - The molecular characteristics of myocarditis associated with immune checkpoint inhibitors are described and potential biomarkers of onset and severity are identified.
0
77
0
RT @sm_blum: We’re excited to see our paper published in @Nature! . Congrats to a fantastic team in the @villanilab and the @MGHCancerCente….
0
5
0
Great opportunity for anyone interested in patient advocacy in dermatology, ideally with lived experience of a skin condition. Feel free to reach out if you have any questions about the role or what it's like working for the BJD in general!.
The BJD is seeking a Patient Associate Editor (PAE) to support our journal’s reach to patients and the lay public!. More information at the link below. The application includes a cover letter and a short CV (2 pages) by January 6, 2025.
0
0
3